Publications by authors named "Bo Mi Ku"

Claim this Profile
U
Updates on the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer.
Jinyong Kim, Sehhoon Park, Bo Mi Ku, Myung-Ju Ahn

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer.
Nayoung Kim, Sehhoon Park, Areum Jo, Hye Hyeon Eum, Hong Kwan Kim, Bo Mi Ku

Elife· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer.
Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, Sehhoon Park, Jong-Mu Sun

J Thorac Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer.
Kyung Hwan Kim, Hongryull Pyo, Hoyoung Lee, Dongryul Oh, Jae Myoung Noh, Bo Mi Ku

Int J Radiat Oncol Biol Phys· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21).
Hyun Ae Jung, Miso Kim, Hae Su Kim, Joo-Hang Kim, Yoon Hee Choi, Bo Mi Ku

J Thorac Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
Joon Young Hur, Bo Mi Ku, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
Minsuk Kwon, Bo Mi Ku, Steve Olsen, Sehhoon Park, Martina Lefterova

Cancer Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
Kyung Hwan Kim, Hongryull Pyo, Hoyoung Lee, Dongryul Oh, Jae Myoung Noh, Bo Mi Ku

Int J Radiat Oncol Biol Phys· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Bo Mi Ku, Jae Yeong Heo, Jinchul Kim, Jong-Mu Sun, Se-Hoon Lee

Invest New Drugs· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
Bo Mi Ku, Yeon Jeong Kim, Donghyun Park, Se-Hoon Lee, Jin Seok Ahn

Oncology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Jiae Koh, Sohyun Kim, Sang Nam Lee, Sun-Young Kim, Jung-Eun Kim, Bo Mi Ku

Nanomedicine· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Sehhoon Park, Steve Olsen, Bo Mi Ku, Min-Sang Lee, Hyun-Ae Jung

Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer.
Sehhoon Park, Chung Lee, Bo Mi Ku, Minjae Kim, Woong-Yang Park

BMB Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.
Bo Mi Ku, Youjin Kim, Kyoung Young Lee, Sang-Yeob Kim, Jong-Mu Sun

Eur J Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade-unresponsive human tumor-infiltrating CD8 T cells are marked by loss of CD28 expression and rescued by IL-15.
Kyung Hwan Kim, Hong Kwan Kim, Hyung-Don Kim, Chang Gon Kim, Hoyoung Lee, Bo Mi Ku

Cell Mol Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With Exon 14 Skipping.
Joon Young Hur, Bo Mi Ku, Joon Ho Shim, Hyun Ae Jung, Jong-Mu Sun

In Vivo· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The First-week Proliferative Response of Peripheral Blood PD-1CD8 T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors.
Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong-Mu Sun

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs.
Kyung Hwan Kim, Joon Young Hur, Jiae Koh, Jinhyun Cho, Bo Mi Ku

Immune Netw· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDSC subtypes and CD39 expression on CD8 T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Jiae Koh, Youjin Kim, Kyoung Young Lee, Joon Young Hur, Mi Soon Kim, Bo Mi Ku

Eur J Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory (FoxP3) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer.
Jiae Koh, Joon Young Hur, Kyoung Young Lee, Mi Soon Kim, Jae Yeong Heo, Bo Mi Ku

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increase of CD8 T cell infiltration following recurrence is a good prognosticator in HNSCC.
Yoon Kyoung So, Sun-Ju Byeon, Bo Mi Ku, Young Hyeh Ko, Myung-Ju Ahn

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn

Cancer Res Treat· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
Jiyun Lee, Bo Mi Ku, Joon Ho Shim, Yoon La Choi, Jong-Mu Sun

Jpn J Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
Nayoung Kim, Hong Kwan Kim, Kyungjong Lee, Yourae Hong, Jong Ho Cho, Bo Mi Ku

Nat Commun· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topological Transformation-Based Nanobarcoding for Detection and Enumeration of MicroRNAs and Single Nucleotide Polymorphism.
Ji Soo Yuk, Seung Won Shin, Sang Hun Chun, Bo Mi Ku, Yu Jeong Choi

Adv Biosyst· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis